Possible Valacyclovir-Related Neurotoxicity and Aseptic Meningitis

Annals of Pharmacotherapy

Volumn 37, Issue 12, 2003, Pages 1814-1817

  Olin, Jacqueline L ^a,b   Gugliotta, Joseph L ^b,c  

^a RUTGERS UNIVERSITY   (United States)

^b Hunterdon Medical Center   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Aseptic meningitis; Valacyclovir

Indexed keywords

ACETYLSALICYLIC ACID; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; MOEXIPRIL; SERTRALINE; TAMSULOSIN; VALACICLOVIR;

AGED; ANAMNESIS; ARTICLE; ASEPTIC MENINGITIS; BALANCE DISORDER; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; HEADACHE; HERPES SIMPLEX; HUMAN; LABORATORY TEST; MALE; NEUROTOXICITY; PRIORITY JOURNAL; RASH; SEIZURE; TONIC CLONIC SEIZURE; X RAY ANALYSIS;

ACYCLOVIR; AGED; AGED, 80 AND OVER; HUMANS; MALE; MENINGITIS, ASEPTIC; NERVOUS SYSTEM DISEASES; VALINE;

EID: 0344412973     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D171     Document Type: Article

References (16)

1. Package insert. Valtrex (valacyclovir). Research Triangle Park, NC: GlaxoSmithKline, 2002.
2. Ernst ME, Franey RJ. Acyclovir- and ganciclovir-induced neurotoxicity. Ann Pharmacother 1998;32:111-3.
3. Haefeli WE, Schoenenberger RAZ, Weiss P, Ritz RF. Acyclovir-induced neurotoxicity: concentration-side effect relationship in acyclovir overdose. Am J Med 1993;94:212-5.
4. Linssen-Schuurmans CD, van Kan EJM, Feith GW, Uges DRA. Neurotoxicity caused by valacyclovir in a patient on hemodialysis. Ther Drug Monit 1998;20:385-6.
5. Maru MC, Fialkow RZ, Haria DM. Choreiform, movements in dialysis patient taking valacyclovir and famciclovir (letter). South Med J 2001;94:655.
6. Izzedine H, Mercadal L, Aymard G, Launay-Vacher V, Martinez V, Issad B, et al. Neurotoxicity of valacyclovir in peritoneal dialysis: a pharmacokinetic study. Am J Nephrol 2001;21:162-4.
7. Fobelo MJ, Corzo Delgado JE, Alonso AR, Gómez-Bellver MJ. Aseptic meningitis related to valacyclovir (letter). Ann Pharmacother 2001;35:128-9. DOI 10.1345/aph.10147
8. Collins A, Krieff D, Smith C, Singer C. Neuropsychiatric toxicity in a patient undergoing hemodialysis and receiving treatment with oral acyclovir. Clin Infect Dis 1996;22:187-8.
9. Jolles S, Carrock Sewell WA, Leighton C. Drug-induced aseptic meningitis: diagnosis and management. Drug Saf 2000;22:215-26.
10. Morris G, Garcia-Monco JC. The challenge of drug-induced aseptic meningitis. Arch Intern Med 1999;159:1185-94.
11. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicellazoster virus. N Engl J Med 2000;342:635-45.
12. Schmader K. Herpes zoster in older adults. Clin Infect Dis 2001;32:1481-6.
13. Echevarria JM, Casas I, Martinez-Martin P. Infections of the nervous system caused by varicella zoster virus: a review. Intervirology 1997;40:72-84.
14. Echevarria JM, Casas I, Tenorio A, de Ory F, Martinez-Martin P. Detection of varicella-zoster virus-specific DNA sequences in cerebrospinal fluid from patients with acute aseptic meningitis and no cutaneous lesions. J Med Virol 1994;43:331-5.
15. Moriuchi H, Moriuchi M, Sun C-C J, Trucksis M. Disseminated cutaneous zoster and aseptic meningitis in a previously healthy patient. J Infect 1997;35:183-5.
16. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.